Damora Therapeutics

(NASDAQ) DMRA

Current Price$24.36

Market Cap$1.50B

Since IPO (2020)-93%

5 Year-80%

1 Year+765%

1 Month-6%

Damora Therapeutics Financials at a Glance

Market Cap

$1.50B

Revenue (TTM)

$0.00

Net Income (TTM)

$235.09M

EPS (TTM)

$-3.46

P/E Ratio

-7.19

Dividend

$0.00

Beta (Volatility)

1.56 (High)

Dividend

$0.00

Beta (Volatility)

1.56 (High)

Price

$24.36

Volume

7,082

Open

$25.02

Price

$24.36

Volume

7,082

Open

$25.02

Previous Close

$24.90

Daily Range

$24.09 - $25.02

52-Week Range

$2.45 - $38.33

Dividend

$0.00

Beta (Volatility)

1.56 (High)

Price

$24.36

Volume

7,082

Open

$25.02

Previous Close

$24.90

Daily Range

$24.09 - $25.02

52-Week Range

$2.45 - $38.33

DMRA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Damora Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Sherwin Sattarzadeh, MBA

Website

www.galecto.com

Headquarters

Boston, MA 02453, US

DMRA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-90%

Return on Capital

-47%

Return on Assets

-44%

Earnings Yield

-13.91%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.50B

Shares Outstanding

60.30M

Volume

7.08K

Avg. Volume

300.10K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$210.87M

EBITDA

$210.84M

Operating Cash Flow

$6.73M

Capital Expenditure

$0.00

Free Cash Flow

$6.73M

Cash & ST Invst.

$257.62M

Total Debt

$68.00K

Damora Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$68.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.50B

N/A

Market Cap/Employee

$214.51M

N/A

Employees

N/A

Net Income

$27.78M

-996.8%

EBITDA

$30.74M

-1086.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$531.56M

+4959.6%

Accounts Receivable

$894.00K

-2.5%

Inventory

$0.00

N/A

Long Term Debt

$1.34M

-5.6%

Short Term Debt

$0.00

-100.0%

Return on Assets

-43.91%

N/A

Return on Invested Capital

-46.73%

N/A

Free Cash Flow

$20.60M

-79.5%

Operating Cash Flow

$20.60M

-79.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7380.40-0.00%

^DJIDJI

^DJIDJI$49554.40-0.00%

^IXICNASDAQ

^IXICNASDAQ$25972.47-0.00%

BTCBitcoin

BTCBitcoin$76868.00+0.01%

AAPLAAPL

AAPLAAPL$298.19+0.00%

AMZNAMZN

AMZNAMZN$259.19-0.02%

GOOGGOOG

GOOGGOOG$386.84-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.79+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.82-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.01+0.01%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$5.17-0.00%

RKTRocket Companies

RKTRocket Companies$12.76-0.02%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$8.21+0.03%

INTCIntel

INTCIntel$111.92+0.03%

Questions About DMRA

What is the current price of Damora Therapeutics?

Damora Therapeutics is trading at $24.36 per share.

What is the 52-week range for Damora Therapeutics?

Over the past 52 weeks, Damora Therapeutics has traded between $2.45 and $38.33.

How much debt does Damora Therapeutics have?

As of the most recent reporting period, Damora Therapeutics reported total debt of $1.34M.

How much cash does Damora Therapeutics have on hand?

Damora Therapeutics reported $532.90M in cash and cash equivalents in its most recent financial results.

What is Damora Therapeutics’s dividend yield?

Damora Therapeutics does not currently have a dividend yield.

Damora Therapeutics

Damora Therapeutics Financials at a Glance

DMRA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Damora Therapeutics

DMRA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Damora Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DMRA

What is the current price of Damora Therapeutics?

What is the 52-week range for Damora Therapeutics?

How much debt does Damora Therapeutics have?

How much cash does Damora Therapeutics have on hand?

What is Damora Therapeutics’s dividend yield?

Premium Investing Services